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ABSTRACT
DNA ligase I-deficient 46BR.1G1 cells show a
delay in the maturation of replicative intermediates
resulting in the accumulation of single- and double-
stranded DNA breaks. As a consequence the
ataxia telangiectasia mutated protein kinase (ATM)
is constitutively phosphorylated at a basal level.
Here, we use 46BR.1G1 cells as a model system to
study the cell response to chronic replication-
dependent DNA damage. Starting from a proteomic
approach, we demonstrate that the phosphorylation
level of factors controlling constitutive and alterna-
tive splicing is affected by the damage elicited
by DNA ligase I deficiency. In particular, we show
that SRSF1 is hyperphosphorylated in 46BR.1G1
cells compared to control fibroblasts. This hyper-
phosphorylation can be partially prevented by
inhibiting ATM activity with caffeine. Notably,
hyperphosphorylation of SRSF1 affects the sub-
nuclear distribution of the protein and the alterna-
tive splicing pattern of target genes. We also unveil
a modulation of SRSF1 phosphorylation after
exposure of MRC-5V1 control fibroblasts to different
exogenous sources of DNA damage. Altogether,
our observations indicate that a relevant aspect
of the cell response to DNA damage involves
the post-translational regulation of splicing factor
SRSF1 which is associated with a shift in the alter-
native splicing program of target genes to control
cell survival or cell death.
INTRODUCTION
DNA replication can pose serious threats to the integrity
of genetic information originating both from errors
of DNA polymerases and from the unwinding of the
double helix that produces highly unstable stretches of
single-stranded DNA. While leading strand replication is
the continuous extension of one primer in the 50 to 30 dir-
ection, lagging strand replication occurs in a discontinu-
ous manner through the synthesis and joining of short
DNA segments, called Okazaki fragments (1). On the
lagging strand, the polymerase a/primase complex synthe-
sizes RNA/DNA primers that are then extended by DNA
polymerase d (pol d) to the full length of Okazaki frag-
ments. When encountering the 50-end of a downstream
Okazaki fragment, pol d strand-displaces the primer into
a single-strand ﬂap that is processed by ﬂap endonuclease
1 (Fen1) to form a nick [reviewed by (2)]. Eventually the
nick is sealed by DNA ligase I (LigI) to yield the continu-
ous double-stranded DNA (3). A SV40 transformed cell
line named 46BR.1G1 has been established from a patient
with a genetic syndrome due to replicative LigI haplo-
insufﬁciency (4). These cells encode a mutated version of
the enzyme in which the conserved Arg 771 in the catalytic
fragment is replaced with a Trp residue. This mutation
slows down the second step of the ligation reaction
allowing the accumulation of nicked DNA-adenylated
intermediates (5). As a consequence 46BR.1G1 cells
show a delayed maturation of Okazaki fragments, which
results in the accumulation of single- and double-stranded
DNA breaks (6,7). These defects can be corrected by
over-expressing the wild-type enzyme as in clone 7A3
(7). Notably, the replication-dependent DNA damage in
LigI-deﬁcient cells fails to halt cell-cycle progression and
to induce apoptosis. Actually, 46BR.1G1 cells display
only a moderate delay in cell-cycle progression and do
not activate the S-phase speciﬁc ATR/Chk1 checkpoint
pathway that also monitors the execution of mitosis,
while the ATM/Chk2 pathway is constitutively activated
at basal level (7,8). Thus, it is presently unknown which is
the strategy used by LigI-deﬁcient cells to cope with this
higher basal level of DNA damage.
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are removed from pre-mRNAs to form mature mRNA
molecules. This reactionis carried outbya complex macro-
molecular machine, the ‘spliceosome’, which consists of
ﬁve small nuclear ribonucleoproteins particles (snRNPs)
and a large number of non-snRNP-splicing factors (9).
With the exception of the ﬁrst and last di-nucleotides at
the intron boundaries, splice sites correspond to short,
loose consensus sequences. This ﬂexibility of the
spliceosome in recognizing different splice site sequences
has been exploited during evolution for an important regu-
latory phenomenon, known as alternative splicing, by
which different combinations of splice sites can be joined
to each other, resulting in the synthesis of several structur-
ally and functionally distinct protein isoforms thereby
enabling large proteomic complexity from a limited
number of genes [reviewed by (10)]. The vast majority
( 90%) of human gene transcripts undergo at least one
alternative splicing event. Usually, the interplay of cis-
acting sequences and trans-acting factors modulates the
splicing of regulated exons. Key cis-acting sequence
elements in splicing regulation are splicing enhancers and
silencers, either exonic or intronic, which respectively
promote or inhibit exon inclusion. In general, splicing en-
hancers are bound and activated by serine/arginine-rich
proteins (SR proteins), which comprise a family of struc-
turally related proteins that are highly conserved through-
out evolution and are involved in both constitutive and
alternative splicing regulation (11). The activity of SR
proteins in alternative splicing can be antagonized by
another group of RNA-binding proteins, the hnRNP
proteins (heterogeneous nuclear ribonucleoprotein).
Owing to its broad impact on gene expression
programs, alternative splicing provides an ideal means to
modulate gene expression to the needs of the cells in
response to stressing conditions. This is even more
evident if one considers that alternative splicing events
are direct targets of signal transduction cascades. Thus,
impacting on speciﬁc signaling pathways could have
drastic effects on splicing of speciﬁc pre-mRNAs, some-
times giving rise to protein isoforms with unique
properties upon stress stimuli.
SRSF1 (12) is the prototypical SR protein. In addition
to its role as a speciﬁc splicing regulator, SRSF1 partici-
pates in other cellular processes as genome maintenance
and cell-cycle progression (13,14). Notably, SRSF1 has
been recently shown to regulate an alternative splicing
network linking cell-cycle control to apoptosis (15).
In this study we use 46BR.1G1 cells as a model system
to study the response to chronic replication-dependent
DNA damage. Starting from a proteomic approach we
demonstrate that SRSF1 phosphorylation is regulated
during the DNA damage response, shifting the alternative
splicing pattern of target genes to control cell survival.
MATERIAL AND METHODS
Drugs, cells lines and cell treatments
Human SV40-transformed ﬁbroblast MRC-5V1 and
46BR.1G1 (European Collection of Cell Cultures #
CB2577) were maintained in monolayer culture in
DMEM supplemented with 10% FBS, 4mM glutamine
and 50mg/ml gentamicin (Sigma). 46BR.1G1 derivative
7A3 (7) was grown in complete DMEM supplemented
with 300mg/ml geneticin (Sigma). To inhibit ATM
kinase activity 46BR.1G1 cells were treated with 2mM
caffeine (Sigma) or 10mM KU-55933 for 24h. To induce
the DNA damage response MRC-5V1 were treated with
100mM etoposide (Sigma) or 2mg/ml aphidicolin (Sigma)
for 3h as previously described (16). For UV treatment
MRC-5V1 were exposed to UV-C radiations (2, 5, 10
and 20J/m
2) and collected after 3h.
2D polyacrylamide gel electrophoresis and mass
spectrometry
Protein concentration was determined at 280nm using the
2D Quant Kit (GE Healthcare). Proteins from total cell
extracts were precipitated with trichloroacetic acid and
run on non-linear (NL) pH 3–10 or linear pH 4–7
gradient range IPG gel strips (length 18cm in both
cases) (GE Healthcare). Strips were re-hydrated in the
swelling solution (8M urea, 4% w/v CHAPS, 65mM
DTE, 0.8% v/v carrier ampholytes and bromophenol
blue) containing 1.3mg of proteins and focused with the
Ettan IPGphor system (GE Healthcare). After focusing
reduction/alkylation steps were performed in rehydration
buffer (6M urea, 2% w/v SDS, 50mM Tris pH 6.8,
glycerol 30%) containing 2% w/v DTE and 2.5% w/v
IAA respectively. The IPG strips were loaded onto
20 18cm 9–16% or constant 9% SDS–polyacrylamide
gels as previously described (17). The 2DE gels were
stained with Coomassie Blue Silver colloidal (18).
Protein patterns were scanned with the VersaDoc
imaging system (BioRad) and analyzed with the
PDQuest Version 7.2 software (BioRad). Only spots
with high quality (>30) were selected. For each cell line
(six replicas) the PDQuest software originated a reference
gel (master gel) including protein spots present in all six
gels. From comparison between the master gels a virtual
image (higher master gel) was created comprehensive of all
matched spots. Standard statistical test [one-way ANOVA
and Bonferroni post hoc test performed using STATA 10
(19)] have been performed to highlight signiﬁcant spots
(P<0.05) for mass spectrometry analyses. For protein
identiﬁcation, spots of interest were excised from SDS–
polyacrylamide gel electrophoresis (PAGE) gels, washed
with 25mM ammonium bicarbonate, dried with acetoni-
trile and digested overnight with modiﬁed sequencing-
grade trypsin (Promega Corporation, Madison, WI,
USA) as described elsewhere (20). Peptide mixture was
analyzed by matrix assisted laser desorption ionization
time of ﬂight (MALDI–TOF–MS): 1ml of the super-
natant of the digestion was spotted in the MALDI plate
using the dried droplet technique and  -cyano-4-
hydroxycinnamic acid (Sigma-Aldrich) as matrix. All
analyses were performed using a Voyager-DE STR
(Applied Biosystems, Framingham, MA, USA) TOF spec-
trometer operating in the delayed extraction mode.
Peptides were measured in the mass range from 750
to 4000Da; all spectra were internally calibrated and
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Biosystems, Framingham, MA, USA). Proteins were un-
ambiguously identiﬁed by mass ﬁngerprint searching
in a comprehensive non-redundant protein database
(Swiss Prot) using Mascot (www.matrixscience.com)
(21). The search parameters were: enzymatic digestion
by trypsin, complete carbamydomethylation on cysteine
residues, variable oxidation of methionine, and 50ppm
mass tolerance.
Cell extract and western blotting
Cell lysate, nuclear extracts and chromatins were prepared
as previously described (22). For 2D western blotting, cells
were harvested in lysis buffer (7M urea, 2M Thiourea and
4% CHAPS) containing protease and phosphatase inhibi-
tors cocktail (Roche), sonicated and then incubated with
DNAse I (Roche) 0.05U/ml for 10min in ice (total cell
extract). After centrifugation the sample (200mg) was
desalted through ZebaTM micro Desalt Spin Column
(Pierce) and loaded on linear pH 3–10 gradient IPG
Strip in IEF buffer [8M urea, 2M Thiourea, 2%
CHAPS, 50mM DTT, 0.2% v/v, BioRad Bio-lyte 3/10
ampholyte, 0.001% (w/v) Bromophenol Blue]. All the
reagents for 2D PAGE were from BioRad. 2D gel electro-
phoresis was performed in Mini-Protean 2D (BioRad) ac-
cording to manufacturer’s instructions. First dimension
was carried out at 400V end voltage. Then IPG Strips
were incubated in equilibration buffer [6M urea,
0.375M Tris–HCl pH 8.8, 2% SDS, 20% glycerol, 2%
(w/v) DTT] for 20min. For the second dimension, IPG
Strips were loaded on a 10% (w/v) SDS–PAGE overlaid
with 0.5% (w/v) Overlay Agarose (BioRad) and run at
200V. For protein dephosphorylation 4.5–5 10
6 cells
were scraped into 150ml of NP-40 lysis buffer (50mM
Tris–HCl pH 8.0, 150mM NaCl, 1% NP-40, 100mg/ml
phenylmethylsulfonyl ﬂuoride and protease inhibitors
cocktail) and sonicated. After centrifugation, the super-
natant was incubated with 500U of alkaline phosphatase
(Roche) for 1h at 37 C. Cell extracts were analyzed by 1D
and 2D western blotting with the following primary
antibodies: anti-Splicing Factor-2 (mAb96) from
Invitrogen Corporation, anti-MEK2 (clone 96) from BD
Bioscience, anti-Actin (2Q1055), anti-PCNA (PC10) and
anti-Orc2 (clone 3G6) from Santa Cruz Biotechnology,
anti-a-tubulin from Sigma, anti-phospho-SR-proteins
(mAb104) from hybridoma cells supernatant (ATCC #
CRL-2067). Primary antibodies were revealed with
peroxidase-conjugated goat anti-mouse, anti-rabbit or
anti-rat antibodies (Jackson Immunoresearch Laborato-
ries) and enhanced chemiluminescence system (Super
Signal West Pico Pierce or Super Signal West Dura
Extended).
RT–PCR
An amount of 1mg of DNAse I-treated total RNA was
retro-transcribed with d(T)18 and MuLV Reverse
Transcriptase (GeneAmp RNA PCR kit, Applied
Biosystem). An aliquot (1ml) was PCR ampliﬁed with
the following pairs of primers: SF2_A_fw (50-AGGAGG
ATTGAGGAGGATCAG-30) and SF2_B_rev (50-CGCT
CCATGAATCCTGGTAA-30); Ron_2507 (50-CCTGAA
TATGTGGTCCGAGACCCCCAG-30) and Ron_2991
(50-CTAGCTGCTTCCTCCGCCACCAGTA-30);
Caspase 9_fw (50-GCTCTTCCTTTGTTCATCTCC-30)
and Caspase 9_rev (50-CATCTGGCTCGGGGTTAC
TGC-30); GAPDH_fw (50-ACCACAGTCCATGCCATC
AC-30) and GAPDH_rev (50-TCCACCACCCTGTTGC
TGTA-30). The intensity of the ampliﬁcation bands
was quantiﬁed with NIH Image J software (version
1.43). Real time quantitative PCR was performed as pre-
viously described (23) with the following sets of primers:
SF2_tot_for (50-CTCCAAGTGGAAGTTGGCAGGAT
T-30) and SF2_tot_rev (50-CTCCAAGTGGAAGTTGG
CAGGATT-30); HP0_for (50-ATGCCCAGGGAAGAC
AGGGCG-30) and HP0_rev (50-CGAAGGGACATGCG
GATCTGCTGC-30).
RESULTS
Proteomic analysis of LigI-deﬁcient 46BR.1G1 cells
In order to gain insights into the mechanisms that allow
46BR.1G1 cell proliferation in the presence of a high level
of replication-dependent DNA damage we compared the
proteomic proﬁles of 46BR.1G1 and of the derivative 7A3
clone stably expressing the human LigI cDNA that
corrects the 46BR.1G1 phenotype (7). By 2D gel electro-
phoresis analysis (six replicas) we identiﬁed 62 spots with
statistically different abundance (P<0.05) in the two cell
lines. Proteins in the 62 spots were identiﬁed by mass spec-
trometry (Supplementary Table SI and Figure 1A):
59 spots corresponded to single proteins while three
spots contained a mix of two proteins. As shown in
Figure 1B, the great majority of the identiﬁed proteins is
involved in the stress response i.e. protein folding and sta-
bilization (13 spots), protein catabolism (four spots)
positive and negative regulators of apoptosis (ﬁve spots),
signal transduction (seven spots) and mitochondrial
proteins and proteins involved in cell redox homeostasis
(seven spots). We also found proteins (six spots) involved
in cytoskeletal organization and cell motility.
Unexpectedly, a relevant fraction of protein (six spots)
differentially expressed in LigI-deﬁcient cells consists of
alternative splicing regulators among which heteroge-
neous nuclear ribonucleoproteins hnRNP C, hnRNP D,
hnRNP H and the prototypical SR factor SRSF1 (already
known as splicing factor 2/alternative splicing factor).
LigI-deﬁciency perturbs the phosphorylation of SRSF1
Several reports have recently suggested a role of SRSF1
in genome integrity and chromatin organization by pre-
venting the formation of R-loops and by modulating the
association of heterochromatin protein 1 (HP1) with chro-
matin (24,25). Moreover SRSF1 has been found to be part
of an alternative splicing network that links cell-cycle
control to apoptosis (15). Thus, we decided to verify
whether SRSF1 was indeed differentially expressed in
LigI deﬁcient cells as suggested by the proteomic
analysis. However, western blot analysis (Figure 2A)
evidenced only a moderate increase (1.26±0.03-fold) in
1108 Nucleic Acids Research, 2012,Vol.40, No. 3the level of SRSF1 in 46BR.1G1 compared to comple-
mented 7A3 cells.
Similarly to all SR splicing factors, SRSF1 is heavily
phosphorylated in the C-terminal domain formed by RS
dipeptides (26); thus, we wondered whether the result of
the proteomic analysis could reﬂect a different protein
phosphorylation in the two cell lines. In an initial
attempt to verify this hypothesis, we probed total cell
extracts from LigI-deﬁcient 46BR.1G1 and LigI-proﬁcient
7A3 cells with the monoclonal antibody clone 104 that
speciﬁcally recognizes phosphorylated SR proteins. As
shown in Figure 2B, the intensity of the signal detected
by mAb104 is considerably stronger in 46BR.1G1 than in
7A3 suggesting a higher phosphorylation level of all SR
factors in LigI deﬁcient cells. In order to explore more in
detail this aspect, we analyzed the 2D immunoblot proﬁle
of SRSF1. Actin, MEK2 and PCNA were used as internal
reference of the isoelectric point (pI). Phosphorylation
produces several isoforms of SRSF1 with different
pI that can be resolved by 2D gel electrophoresis
(Figure 3A). For a better comparison, the densitometric
proﬁle of SRSF1 is shown alongside each gel (Figure 3B).
The SRSF1 isoforms distribution in control MRC-5V1
ﬁbroblasts develops into two main pools: an acidic one
(pool A), with a broad distribution in the range of pI
from 4 to 5, and a more basic pool (pool B) focusing
with a pI of 6.5/7. A drastically different distribution is
detectable in 46BR.1G1 with a general shift toward lower
pI. In particular, in LigI-deﬁcient cells pool A extends
between pI 3.5 and 5, while pool B migrates at the same
pI as MEK2 (5.5/6). Remarkably the migration proﬁle
observed in normal ﬁbroblasts is re-established upon
stably expression of wild-type LigI in 46BR.1G1 as
indicated by the 2D western blotting of 7A3 cells
extract. This ﬁnding strongly supports the conclusion
that SRSF1 phosphorylation is modulated in response to
the DNA damage elicited by LigI deﬁciency.
In 46BR.1G1 cells the ATM kinase is constitutively
phosphorylated on serine 1918 (7) and this activation is
reverted in 7A3 cells. We wondered whether or not the
change in the 2D gel proﬁle of SRSF1 could be triggered
by the chronic activation of the DNA damage
checkpoint. To verify this hypothesis, we analyzed the
2D immunoproﬁle of SRSF1 in 46BR.1G1 grown for
24h in 2mM caffeine, an inhibitor of checkpoint
kinases. As shown in Figure 3A and B, upon treatment
with caffeine the 2D gel proﬁle of SRSF1 shifts toward
higher pI although the migration of pool B observed in
normal ﬁbroblasts is not re-established. To prove that the
acidic pool of SRSF1 observed in 46BR.1G1 cells was
indeed due to protein hyper-phosphorylation, the cell
extract was incubated with alkaline phosphatase before
Figure 1. Proteins with differential expression in 46BR.1G1 and 7A3
cells as shown by 2D electrophoresis. (A) Representative 2D gel
analysis of 46BR.1G1 LigI-defective (left) and 7A3 cells expressing
the wild-type LigI cDNA (right). Proteins were focused on IPG strip
non-linear pH 3-10 (a) or linear pH 4-7 (b–d) gradient ranges and then
separated into 9–16% (a) or constant 9% (b–d) polyacrylamide gels.
Gels were stained with Coomassie Blue Silver colloidal. Corresponding
expanded areas of gels for the two cell lines are shown. Arrows point to
spots that reproducibly showed volume variations in six independent
replicas. Proteins in the indicated spots were eluted and identiﬁed by
mass spectrometry (see ‘Materials and Methods’ section). (B) All spots
with differential expressions were analyzed by mass spectrometry and
assigned with the indicated functional categories.
Figure 2. SRSF1 expression and phosphorylation of SR proteins in
46BR.1G1 and 7A3 cells. (A) Cell lysates from 46BR.1G1 and 7A3
cells were analyzed by western blotting with anti-SRSF1 (mAb96)
and anti-a-tubulin antibodies. Quantiﬁcation of the assay was per-
formed by densitometric analysis with the NIH ImageJ 1.43 program.
Bars show means±SEM of three independent experiments. (B) Cell
lysates from 46BR.1G1 and 7A3 cells were analyzed by western
blotting with anti-SR-phosphoepitopes antibody (mAb104) and
anti-a-tubulin antibody.
Nucleic Acids Research,2012, Vol.40, No. 3 11092D western blot analysis. As shown in Figure 3A and B
(bottom plot), the acidic pool disappeared after protein
dephosphorylation and most SRSF1 focused in a few
spots with a pI>6.
LigI-deﬁciency affects localization and activity of SRSF1
The extensive serine phosphorylation of the RS domain
is important to regulate the localization and activity
of SRSF1. However, no difference was visible in the dis-
tribution of SRSF1 between 46BR.1G1 and 7A3 cells
by immunoﬂuorescence (data not shown). Thus, we
investigated the distribution of SRSF1 in the same cell
lines after biochemical cell fractionation. Cytoplasmic
(S1), nucleoplasmic (S3) and chromatin enriched (P3) frac-
tions were prepared from 46BR.1G1 and 7A3 cells as pre-
viously described (22). Extracts were then analyzed in
western blotting; MEK2 and Orc2 were used as markers
Figure 3. SRSF1 is hyperphosphorylated in 46BR.1G1 cells. (A) 2D western blot analyses of total extracts from MRC-5V1, 7A3 and 46BR.1G1 cells
with anti-SRSF1, anti-MEK2, anti-actin and anti-PCNA antibodies. A total extract was also prepared from 46BR.1G1 cells after 24h incubation in
2mM caffeine to inhibit checkpoint kinases activity. The isoelectric proﬁle of SRSF1 was also determined after incubation of 46BR.1G1 cell extract
with alkaline phosphatase. Caffeine and alkaline phosphatase treatments are indicated alongside the gel. (B) The signal of SRSF1 was quantiﬁed with
the NIH ImageJ 1.43 version program: the x-axis represents the distance from the anode and the y-axis measures the pixel intensities.
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As shown in Figure 4, under these experimental conditions
SRSF1 is exclusively found in the nuclear fractions of
both cell lines. However, a difference in the subnuclear
distribution of SRSF1 is clearly visible, and the fraction
of the protein in the soluble nucleoplasm increases from
2% in 7A3 cells to  20% in 46BR.1G1.
It has been shown that transcription inhibition leads to
translocation of SRSF1 from the nucleoplasm to nuclear
speckles (27) indicating that the nucleoplasmic fraction
comprises the pool of SRSF1 involved in pre-mRNA pro-
cessing. Thus, one can predict that an increased amount of
SRSF1 in the nucleoplasmic fraction of 46BR.1G1 cell
could affect the alternative splicing proﬁle of target gene
transcripts. One of the best-characterized targets of
SRSF1 is Ron proto-oncogene, which encodes the
human receptor for the macrophage-stimulating protein
(MSP) (28). SRSF1 controls the choice between skipping
versus inclusion of Ron exon 11 (Figure 5A): high levels of
SRSF1 induce skipping of exon 11 and the production of
Ron. RT–PCR analysis (Figure 5B) indicates that the
full length Ron isoform prevails in 7A3 cells while Ron
increases in 46BR.1G1 cells. SRSF1 also functions as
regulator of caspase-9 (Casp9) pre-mRNA processing
(15). Two splice variants (pro-apoptotic Casp9a and
anti-apoptotic Casp9b) are encoded by the Caspase 9
gene through alternative splicing of a cassette composed
of exons 3, 4, 5 and 6 (Figure 5A). It has been recently
shown that phosphorylation of the RS domain of SRSF1
is critical in promoting the Casp9b-splicing variant (29).
In agreement with these observations RT–PCR analyses
show a reduction of Casp9a/Casp9b ratio in 46BR.1G1
versus 7A3 cells (Figure 5B). Therefore, the alternative
splicing proﬁles of SRSF1 target genes differ in
46BR.1G1 versus 7A3 cells in parallel with the increased
level in the nucleoplasm and phosphorylation of SRSF1.
This conclusion is also supported by the analysis of two
additional splicing events controlled by SRSF1, namely
RPS6KB1 and MKNK2 genes (Supplementary Figure
S1) (30).
In order to understand the role of checkpoint activation
in the difference of splicing proﬁles between 46BR.1G1
and 7A3 cells, we decided to investigate the effect of
caffeine, a general inhibitor of checkpoint kinases, and
of KU-55933, that speciﬁcally inhibits the ATM
pathway (31). Therefore, 46BR.1G1 were incubated for
24h in the presence of caffeine or KU-55933 before
RNA puriﬁcation. The RT–PCR analyses in Figure 5C
show that both inhibitors affect Ron/Ron and Casp9a/
Casp9b ratios in 46BR.1G1 cells reverting them to values
comparable to those observed in 7A3 cells. No effect is
detectable in 7A3 cells expressing the wild-type LigI (data
not shown). These data indicate that the LigI defect,
which results in a high level of replicative DNA damage,
impacts the alternative splicing of SRSF1 target tran-
scripts in ATM-dependent manner. The different phos-
phorylation status of SR proteins and of SRSF1 in
particular between 46BR.1G1 and 7A3 cells (Figures 2
and 3) seems to be relevant for this event.
Different DNA damages perturb SRSF1 phosphorylation
The results in Figure 3 indicate that SRSF1 is regulated at
the post-translational level in response to the increased
basal level of endogenous DNA damage observed in
LigI-deﬁcient cells. We wondered whether the acute
exposure to exogenous sources of DNA damage could
affect the protein phosphorylation as well. To answer
this question we have investigated by 2D gel western
blotting the isoelectric proﬁle of SRSF1 in MRC-5V1
human ﬁbroblasts before and after treatment with three
different DNA damaging agents inducing speciﬁc DNA
damage responses: ultraviolet irradiation (UV), etoposide
and aphidicolin. Contrary to LigI-deﬁciency all these
DNA damages induce cell-cycle arrest although by differ-
ent mechanisms. UV and aphidicolin induce stalling of
replication forks that need to be stabilized by the
ATR-dependent checkpoint pathway (32). Etoposide
is a Topo II poison that induces both ATR- and
ATM-dependent checkpoint pathways (16). Human
MRC-5V1 ﬁbroblasts were treated with the different
agents as described in ‘Materials and Methods’ section,
after 3h cells were lysed and total extracts were run on
2D gels. As shown in Figure 6 all these treatments affect
the isoelectric proﬁle of SRSF1. However contrary to
what observed in LigI-deﬁcient cells they promote a shift
toward higher isoelectric points and the disappearance of
the acidic tail detectable in the extract of untreated cells.
Thus SRSF1 phosphorylation is modulated in response to
a wide set of endogenous and exogenous agents that threat
genome integrity. Notably, in response to UV irradiation
there is also a drastic reduction in the abundance of the
basic pool B. Altogether these results indicate the SRSF1
is a target of post-translational modiﬁcations triggered
by different types of DNA damages.
Figure 4. The nucleoplasmic fraction of SRSF1 increases in 46BR.1G1
cells. Exponentially growing 46BR.1G1 and 7A3 cells were fractionated
to obtain the chromatin enriched (P3), nucleoplasmic (S3) and cyto-
plasmic (S1) fractions. Cell fractions were analyzed by western blotting
with anti-SRSF1, anti-Orc2, anti-MEK2 and anti-actin monoclonal
antibodies. The percentage of SRSF1 in P3 and S3 fractions is the
mean of two independent experiments.
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SRSF1 transcripts
In spite of the slight increase of SRSF1 protein
(Figure 2A) RT-qPCR analysis does not reveal a statistic-
ally signiﬁcant difference in the amount of SRSF1 tran-
script between 46BR.1G1 and 7A3 cells (data not shown).
We have recently shown that the level of SRSF1 protein
can be controlled through an alternative splicing event
involving an intron in the 30-UTR region (30-UTR
intron) of the gene. Splicing of this intron results in a
mRNA molecule (NMD+ RNA, Figure 7A) in which
the natural stop codon is recognized as a premature ter-
mination codon (PTC) (23) leading to mRNA degradation
by the nonsense mediated RNA decay (NMD) pathway
after the ﬁrst round of translation. Based on this know-
ledge, we have compared the splicing proﬁle of the
30-UTR intron in MRC-5V1 control ﬁbroblasts,
46BR.1G1 and complemented 7A3 cells. As shown in
Figure 5. The alternative splicing of SRSF1 target genes Ron and caspase 9 is altered in LigI-deﬁcient cells. (A) Schematic representation of
alternative splicing in Ron and Caspase 9 transcript. (B) Total RNAs from 46BR.1G1 and 7A3 cell lines were analyzed by RT–PCR with Ron
primers 2507 and 2991 annealing to exon 10 and exon 12 respectively, with Caspase 9_fw and Caspase 9_rev primers annealing to exon 2 and exon 7
respectively, and with speciﬁc primers for the GAPDH control mRNA. The Ron/Ron and Caspase9a/Caspase9b ratios were calculated on the basis
of the intensity of the ampliﬁcation bands quantiﬁed with the NIH ImageJ 1.43 program and are indicated below each lane. (C) The same ratios were
calculated in 46BR.1G1 untreated and treated for 24h with 2mM caffeine or 10mM KU-55933. M, DNA size markers.
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accounts for  5% of the total signal in control human
ﬁbroblasts (MRC-5V1) and in cells stably expressing
wild-type LigI (7A3) while it is barely detectable in
46BR.1G1 cells. Taking into accounts the different
length of the two ampliﬁcation bands (100 and 1000nt
respectively for the NMD+ and full-length splicing
isoforms) the RT–PCR analysis indicates that in molar
terms the NMD+ mRNA represents  30% of total
SRSF1 RNA in 7A3 cells. Thus, the different splicing of
SRSF1 transcript could explain the difference in protein
level observed in Figure 2. Interestingly, a change in the
splicing proﬁle of SRSF1 transcript is elicited also by UV
light and results in an increased splicing of the 30-UTR
intron in a dose-dependent manner (Figure 7C and D).
In the considered time interval (3h after UV irradiation)
we did not detect signiﬁcant variation in the amount of
SRSF1 protein (data not shown).
DISCUSSION
DNA ligase I deﬁciency in 46BR.1G1 cells severely
impacts the maturation of newly synthesized DNA (7).
This defect results in an increased level of endogenous
DNA damage as revealed by phosphorylation of the
histone variant H2AX and the formation of gH2AX
foci, which are markers of DSBs (33). Although import-
ant, the LigI defect in 46BR.1G1 cells does not block
cell-cycle progression and elicits only a moderate activa-
tion of the checkpoint pathway identiﬁed by ATM/Chk2
kinases. Notably, the expression of ectopic wild-type LigI
(7A3 cells) reverses all these effects (7).
This peculiar phenotype of 46BR.1G1 cells makes them
a suitable system to investigate the strategies used by the
cells to cope with an increased endogenous level of DNA
replication dependent DNA damage that, nevertheless,
is compatible with survival and proliferation. As a ﬁrst
attempt to address this issue, we applied a proteomic
approach aimed at identifying proteins differentially
expressed and/or post-translationally modiﬁed in LigI-
deﬁcient cells compared to normal MRC-5V1 ﬁbroblasts
and to 7A3 cells. This analysis identiﬁed a small set of
proteins most of which appear to be involved in the
stress response and in the organization of the cytoskel-
eton. Interestingly, a fraction of the identiﬁed proteins
consists of factors with a role in alternative splicing of
gene transcripts (see the list in Supplementary Table S1).
A still growing body of experimental evidences implicates
splicing regulators in the DNA damage response (DDR)
and in genome stability. These factors appear to act by
Figure 6. Phosphorylation of SRSF1 changes in response to DNA damaging agents. Total cell extracts from MRC-5V1 human ﬁbroblasts untreated
and treated with the indicated DNA damaging agents were analyzed by 2D western blotting. Filters were incubated with anti-SRSF1, anti-PCNA,
anti-MEK2 and anti-actin monoclonal antibodies. The densitometric proﬁle of SRSF1 is shown alongside each gel. The x-axis represents the distance
from the anode and the y-axis the pixel intensity (NIH ImageJ 1.43).
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proteins that are critical for the proper cell response to
stress, as for instance p53 and its regulator MDM2 (34).
Moreover, some splicing factors have an additional
and evolutionary conserved role in genome maintenance
programs. Indeed, both in yeast and in mammals, a subset
of splicing regulators is required to prevent the
cotranscriptional generation of R-loops that are thought
to results from inefﬁcient processing of the nascent RNA
molecule and the ensuing hybridization of the nascent
transcript with the template DNA (RNA–DNA hybrid)
(24,35). How R loops might lead to genome instability is
unclear. One possibility is that the displaced ssDNA is
more susceptible to DNA damage, ultimately leading
to DSB formation and recombination. Alternatively,
R-loops could represent DNA replication fork barriers
and cause fork arrest and collapse (24). More recently,
the link between RNA processing factors and DDR has
been reinforced by genome-wide analyses for modulators
of DNA damage signaling (36,37). Interestingly, the
largest fraction of identiﬁed genes encodes proteins with
functions in mRNA binding and processing including
SFSR1 and hnRNP C that belong to the set of proteins
selected by our proteomic approach.
DNA damage controls the phosphorylation proﬁle
of SRSF1
Because of these considerations, we decided to investigate
more in detail the splicing regulator SRSF1. Interestingly,
LigI deﬁciency only modestly affects the SRSF1 protein
level (Figure 2), while it drastically perturbs the phosphor-
ylation pattern as indicated by the altered electrophoretic
mobility in 2D gel. The impact on protein phosphoryl-
ation is probably not speciﬁc to SRSF1 since western
blot analysis with the mAb104, which recognizes
phosphorylated SR factors, suggests a broad effect on
the whole family of these splicing regulators. Thus, en-
dogenous DNA damage in 46BR.1G1 cells appears to
elicit a signaling pathway that targets proteins involved
in pre-mRNA processing. In agreement with this inter-
pretation we have observed that caffeine, which inhibits
ATM and ATR kinases, partially prevents SRSF1
hyper-phosphorylation in 46BR.1G1 cells.
Alternative splicing is a predominant mechanism of
gene expression regulation only in higher eukaryotes, spe-
ciﬁcally in mammals. However, basic components of the
splicing machinery are conserved between yeast and
human. Among yeast SR-like proteins, Npl3 displays
some structural and functional features of SRSF1,
including the presence of a non-canonical RRM (RNA
Recognition Motif), the involvement in pre-mRNA pro-
cessing, RNA export and translation. Both Npl3 and
SRSF1 may auto-regulate their expression at the
post-transcriptional level and undergo multiple phosphor-
ylation events (38,39). Whether Npl3 inactivation induces
genome instability is not presently known, but Npl3p
mutants show hypersensitivity to DNA damaging agents
(40). In agreement with our observations recent proteomic
analyses have identiﬁed Npl3 as a target of DDR activated
kinases Mec1 and Tel1 (41), homolog of mammalian ATR
Figure 7. The alternative splicing of SRSF1 is modiﬁed in 46BR.1G1
cells and is regulated in response to UV-light. (A) Schematic repre-
sentation of alternative splicing in the 30-UTR of SRSF1 transcripts.
FL, full-length transcript of SRSF1; NMD
+, splicing variant
associated with the non-sense mediated mRNA decay pathway.
(B) Total RNA from 46BR.1G1, 7A3 and MRC.5V1 cell lines was
analyzed by RT–PCR with primers that recognized both the FL and
NMD
+ mRNAs of SRSF1 (arrows) and with speciﬁc primers for the
GAPDH control mRNA. The asterisk indicates an unspeciﬁc PCR
product. M, DNA size markers. (C) Total RNA from the MRC-5V1
control ﬁbroblasts untreated or treated with different damaging
agents was analyzed by RT–PCR (30 cycles) as in (B) with primers
speciﬁc for SRSF1 and GAPDH mRNAs. The asterisk indicates
an unspeciﬁc PCR product. (D) Total RNA was puriﬁed from
MRC-5V1 3h after exposure to the indicated UV doses and
analyzed by RT–PCR (25 cycles) with primers that recognized both
the FL and the NMD
+ mRNA of SRSF1 (arrows) and with primers
for the GAPDH control mRNAs. M, DNA size markers. The ratio
between FL and NMD
+ bands indicated under each line was
calculated on the basis of the intensity of the bands quantiﬁed
with the NIH ImageJ 1.43.
1114 Nucleic Acids Research, 2012,Vol.40, No. 3and ATM kinases. Smolka and collaborators have
demonstrated a DNA damage-dependent phosphoryl-
ation of Npl3 on serine 224 located in the non canonical
RRM domain (RRM2) and adjacent to a heptapeptide
(SWQDLKD218) 100% conserved in the human protein
and organized in an a helix. Interestingly, a putative phos-
phorylation site is predicted by the NetPhos 2.0 server
(http://www.cbs.dtu.dk) at Ser 131 adjacent to the
heptapeptide (residues 133–139) of human SRSF1 and a
prediction of a chk1/chk2 phosphorylation site on Ser 131
is also provided by the PPSP site (http://ppsp.biocuckoo
.org). In view of the importance that the heptapeptide
has in the activity of SRSF1 in alternative splicing (42),
it is conceivable to hypothesize important functional
consequences of phosphorylation of nearby residues.
However, so far we were unable to provide evidence
of Ser 131 phosphorylation in vivo, by mass spec-
trometry analysis of the immunoprecipitated SRSF1.
The relevance of our ﬁndings to genome-safeguard
strategies is indicated also by the observation that
post-translational modiﬁcation of SRSF1 is modulated
in response to a variety of exogenous DNA damaging
agents. Remarkably, each stressing agent appears to
induce a speciﬁc change in the electrophoretic mobility
of the protein suggesting the activation of distinct signal-
ing pathways.
Post-translational modiﬁcation of SRSF1 and
alternative splicing
As stated above the endogenous DNA damage in
46BR.1G1 cells affects the post-translational modiﬁcation
of a number of splicing regulators in addition to SRSF1,
which hampers the possibility to establish a direct link
between SRSF1 phosphorylation and changes in alterna-
tive splicing events. However, a number of evidences are
consistent with this possibility. First of all, the increased
phosphorylation is accompanied by the shift of SRSF1
from the nuclear pellet to the nucleoplasm (Figure 4)
which suggests that a larger pool of protein is actually
engaged in pre-mRNA processing in 46BR.1G1 cells
compared to normal ﬁbroblasts. Second evidence comes
from the analysis of the splicing proﬁle of Ron oncogene.
We have previously shown that the level of SRSF1
controls splicing of Ron exon 11 and upregulation or
over-expression of this splicing factor induces exon
skipping (28). The modest difference in the SRSF1 level
(1.3-fold) between 46BR.1G1 and 7A3 cells points to
protein phosphorylation as the main cause of the drastic-
ally different splicing proﬁle of exon 11 in the two cell
lines. This conclusion is further supported by the observa-
tion that upon inhibition of checkpoint with caffeine or
KU-55933 the splicing proﬁle of Ron transcript in
46BR.1G1 cells becomes comparable to that observed
in 7A3 cells. Similar consideration can be raised for the
splicing proﬁle of the caspase 9 RNA. Remarkably, the
splicing variants of Ron and caspase 9 genes expressed
in 46BR.1G1 cells are known to have anti-apoptotic
activity which is consistent with the reported involve-
ment of SRSF1 in anti-apoptotic pathways (15). On
the contrary dephosphorylation of SR proteins after
FAS activation enhances the execution of the apop-
totic response (43). In line with this observation the
reduction in the phosphorylation level of SRSF1
after UV-light treatment affects the alternative splicing
of Ron exon 11 and reduces the expression of the
anti-apoptotic Ron in a dose-dependent manner
(Supplementary Figure S2).
Alternative splicing of SRSF1 transcripts is controlled
by DNA damage
The 30-UTR of the SRSF1 pre-mRNA contains an intron
(30-UTR-intron) that is normally retained in the mature
transcript. Splicing of the 30-UTR-intron leads to the pro-
duction of the NMD+transcript in which the natural stop
codon is recognized as a premature stop codon and the
mRNA degraded by the nonsense-mediated RNA decay
(NMD) pathway. This alternative splicing event is one of
the molecular mechanisms that control SRSF1 expression
(44). We have recently shown that splicing of the 30-UTR-
intron is modulated during in vitro epithelial to mesenchy-
mal transition (23). In epithelial cells most of SRSF1
pre-mRNA undergoes splicing of the 30-UTR-intron
with the production of the NMD sensitive mRNA. On
the contrary, splicing of the intron is prevented in mesen-
chymal cells. In this manuscript we have shown that the
ratio between the full length and the NMD
+ splicing
isoform is also affected by DNA damaging agents. In par-
ticular it is perturbed by the replication dependent DNA
damage mediated by LigI deﬁciency in 46BR.1G1 cell line.
Among the exogenous DNA damaging agents tested in
this study only UV-light drastically affects SRSF1
splicing and increases the production of the NMD+
mRNA in a dose dependent manner. It has been
recently described a cotranscriptional mechanism for
activating alternative pre-mRNA splicing after
UV-irradiation that depends on hyperphosphorylation of
the RNA polymerase II C-terminal domain and decreased
rates of transcription elongation (45). Interestingly the
fraction of genes that undergo a change in the alternative
splicing after UV-light treatment is largely enriched
in those genes that also show downregulated expression,
suggesting that control of alternative splicing through
its coupling with transcription is a key feature of the
DNA-damage response. Moreover, these events appear
not to be controlled by checkpoint pathways as indicated
by the insensitivity to caffeine treatment. The fact that,
differently form the other AS events considered in this
study, splicing of the 30-UTR intron is not modulated by
ATM abrogators, caffeine and KU-55933 (data not
shown), suggests the possibility that the elongation rate
of RNA polymerase II may play a role in this event.
In conclusion, our observations, along with a growing
list of evidences from other laboratories, are uncovering
the existence of a DNA damage signal transduction
pathway that directly regulates the splicing factors and
suggest that the regulation of alternative splicing is a
mechanism allowing cells to rapidly modify gene expres-
sion by adapting to new stress conditions.
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